JD HEALTH INTL LTD (8ZN) — Capital Reinvestment Ratio
Latest as of June 2023:
0.11x
JD HEALTH INTL LTD (8ZN) has a Capital Reinvestment Ratio of 0.11x as of June 2023, meaning it reinvests 0% of its operating cash flow (€184.04 Million) in capital expenditures (€19.75 Million). See 8ZN FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.11x
Capex / Operating Cash Flow
Operating Cash Flow
€184.04 Million
EUR
Capital Expenditures
€19.75 Million
EUR
Data as of
Jun 2023
Most recent filing
JD HEALTH INTL LTD Capital Reinvestment Ratio (2019–2025)
This chart tracks JD HEALTH INTL LTD's Capital Reinvestment Ratio across 7 annual periods.
Annual Capital Reinvestment Ratio for JD HEALTH INTL LTD (2019–2025)
Year-by-year Capital Reinvestment Ratio for JD HEALTH INTL LTD from 2019 to 2025. For live market cap and broader valuation context, see JD HEALTH INTL LTD (8ZN) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | €10.17 Billion | €151.01 Million | ▲ +38.7% |
| 2024 | 0.01x | €4.33 Billion | €46.35 Million | ▼ -28.9% |
| 2023 | 0.02x | €4.60 Billion | €69.33 Million | ▲ +121.4% |
| 2022 | 0.01x | €5.91 Billion | €40.16 Million | ▼ -95.4% |
| 2021 | 0.15x | €3.43 Billion | €502.21 Million | ▲ +3349.6% |
| 2020 | 0.00x | €3.70 Billion | €15.70 Million | ▼ -66.5% |
| 2019 | 0.01x | €409.47 Million | €5.19 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow